Metodología para la gestión de riesgos asociados al suministro de medicamentos de alto costo

The supply of high-cost drugs in pharmaceutical services involves a set of critical processes that often generate economic losses for these organizations. The absence of standardized processes, together with the high probability of errors associated with the handling of these drugs, are part of a re...

Full description

Autores:
Galeano Ruiz, Angie Viviana
Tipo de recurso:
Fecha de publicación:
2022
Institución:
Universidad Santo Tomás
Repositorio:
Repositorio Institucional USTA
Idioma:
spa
OAI Identifier:
oai:repository.usta.edu.co:11634/42198
Acceso en línea:
https://revistas.usantotomas.edu.co/index.php/signos/article/view/7482
Palabra clave:
Risk management
ISO 31000 standard
Methodological guide
Critical processes
Pharmaceutical services
Drug supply
Gestión de riesgo
Norma ISO 31000
Guía metodológica
Procesos críticos
Servicios farmacéuticos
Suministro de medicamentos
Gestão de risco
norma ISO 31000
guia metodológico
processos críticos
serviços farmacêuticos
fornecimento de medicamentos
Rights
License
Derechos de autor 2021 SIGNOS - Investigación en sistemas de gestión
Description
Summary:The supply of high-cost drugs in pharmaceutical services involves a set of critical processes that often generate economic losses for these organizations. The absence of standardized processes, together with the high probability of errors associated with the handling of these drugs, are part of a recurring panorama that imposes the need to implement effective strategies to mitigate these losses within these organizations. As a strategy, the proposed methodological guide for the management of risks associated with the supply of high-cost drugs is presented, which is developed in six (06) steps that include: discrimination of the context; risk identification; the classification of the risk; risk analysis; risk assessment; and finally, the treatment, monitoring and review of risk. All this structured from the NTC-ISO 31000: 2018 standard, which allows it to become a tool that is easy to implement, and highly useful for treating the different risks that arise with the drug supply process. This methodological guide has been developed from a descriptive method of reviewing sources and qualitative and quantitative data.